Cabaletta Bio (CABA) Research & Development (2018 - 2025)

Cabaletta Bio's Research & Development history runs 8 years deep, the most recent figure standing at $36.2 million for Q4 2025.

• In Q4 2025, Research & Development rose 57.37% year-over-year to $36.2 million; the TTM figure through Dec 2025 stood at $142.7 million (up 50.71% YoY), while the FY2025 annual figure was $142.7 million, up 46.78% from the prior year.
• Research & Development was $36.2 million for Q4 2025 at Cabaletta Bio, down from $39.8 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $39.8 million in Q3 2025 to a low of $6.6 million in Q1 2021.
• Historically, Research & Development has averaged $18.2 million across 5 years, with a median of $13.1 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Research & Development advanced 0.58% in 2022, then surged 98.58% in 2024.
• A 5-year view of Research & Development shows it stood at $9.9 million in 2021, then rose by 25.01% to $12.4 million in 2022, then surged by 40.36% to $17.4 million in 2023, then soared by 32.15% to $23.0 million in 2024, then surged by 57.37% to $36.2 million in 2025.
• The last three Research & Development figures came in at $36.2 million (Q4 2025), $39.8 million (Q3 2025), and $37.6 million (Q2 2025), per Business Quant data.